Top Markets
Coin of the day
Gongwin Biopharm Holdings Co., Ltd. Gongwin Biopharm Holdings Co., Ltd.

Gongwin Biopharm Holdings Co., Ltd.

6617
Rangering i aksjer #13752
Gongwin Biopharm Holdings Co., Ltd. is a clinical-stage biopharmaceutical... Gongwin Biopharm Holdings Co., Ltd. is a clinical-stage biopharmaceutical company specializing in the development of oncology therapeutics. The company's robust pipeline features several drug candidates, including PTS302, which has successfully concluded Phase III clinical trials for lung cancer. Additionally, PTS100 is currently progressing through Phase II clinical trials for liver cancer, while PTS-02 is being developed to address adenoid cystic carcinoma, and PTS500 targets malignant pleural effusion. Established in 2014, Gongwin Biopharm is headquartered in Taipei, Taiwan.
Aksjekurs
$3.83
Markedsverdi
$464.45M
Endring (1 dag)
-1.63%
Endring (1 år)
17.17%
Land
TW
Handel Gongwin Biopharm Holdings Co., Ltd. (6617)

Kategori

Aksjeprishistorikk for Gongwin Biopharm Holdings Co., Ltd. (6617)
Høyeste sluttskurs: $3.43 den 2026-08-01

Laveste sluttskurs: $2.71 den 2017-02-01
Aksjeprishistorikk for Gongwin Biopharm Holdings Co., Ltd. fra 2017 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -1.11%
2025 -19.11%
2024 -45.63%
2023 -41.34%
2022 10.61%
2021 7.85%
2020 318.74%
2019 -1.25%
2018 12.21%
2017 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$885.01 28.89%
US
$323.36 10.89%
US
$234.55 57.65%
US
$187.22 0.00%
US
$1.90 -7.01%
AU